Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 807-596-9 | CAS number: 1428451-07-3
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
The dermal sensitisation potential of 2',4'-Bis(methoxycarbonyloxy)-2 -brom-acetophenone was assessed in accordance with OECD guideline 429 ("Skin Sensitisation: Local Lymph Node Assay").
Under the conditions of the study 2',4'-Bis(methoxycarbonyloxy)-2 -brom-acetophenone showed sensitising potential.
Key value for chemical safety assessment
Skin sensitisation
Link to relevant study records
- Endpoint:
- skin sensitisation: in vivo (LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- April - July 2015
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay)
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.42 (Skin Sensitisation: Local Lymph Node Assay)
- GLP compliance:
- yes (incl. QA statement)
- Type of study:
- mouse local lymph node assay (LLNA)
- Species:
- mouse
- Strain:
- other: CBA/CaOlaHsd
- Sex:
- female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: Harlan Laboratories B.V., Postbus 6174, 5960 AD Horst, The Netherlands
- Age at study initiation: 8 -12 weeks
- Weight at study initiation: 18.8 - 21.2 g
- Housing: group housing in Makrolon Type II (pre-test) and III (main study) with wire mesh top
- Diet (e.g. ad libitum): 2018C Teklad Global 18% protein rodent diet (certified), ad libitum
- Water (e.g. ad libitum): tap water, ad libitum
- Acclimation period: at least five days prior to the start of dosing under test conditions after health examination
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22 +/- 2 °C
- Humidity (%): The relative humidity in the animal room was between approximately 45 – 81.5 % instead of 45 – 65% for approx. 9 hours.
This deviation to the study plan, however, does not affect the validity of the study, as a temporary alteration in relative humidity over several hours is not considered to have any influence on the test system and the test results obtained. Furthermore, according to Test Guideline OECD 429 a relative humidity of 30 – 70% (with values above 70% of a short duration during room cleaning procedures) is acceptable.
- Photoperiod (hrs dark / hrs light): artificial light from 6.00 a.m. - 6.00 p.m. - Vehicle:
- dimethylformamide
- Concentration:
- Main Test: 0.05, 0.1 and 0.25 %
Pre-Test: 50, 25, 10, 5, 2.5, 1, 0.5, 0.25 and 0.1 % - No. of animals per dose:
- Main Test: five animals per dose
Pre-Test: one animal per dose - Details on study design:
- see "any other information on material and methods incl. tables"
- Positive control substance(s):
- hexyl cinnamic aldehyde (CAS No 101-86-0)
- Statistics:
- The mean values and standard deviations were calculated in the body weight tables and for the DPM values (group mean DPM ± standard deviation).
The EC3 value was calculated according to the equation
EC3 = (a-c) [(3-d)/(b-d)] + c
where EC3 is the estimated concentration of the test item required to produce a 3-fold increase in draining lymph node cell proliferative activity; (a, b) and (c, d) are respectively the co-ordinates of the two pair of data lying immediately above and below the S.I. value of 3 on the local lymph node assay dose response plot.
The Dean-Dixon-Test and the Grubb’s test were used for identification of possible outliers (performed with validated program R Script Outlier.Rnw). An outlier (animal 20) was identified in both outlier tests. However since exclusion of the outlier value would not change the overall test result, the value in question was not excluded from calculations.
A statistical analysis was conducted on the ear weights to assess whether the difference was statistically significant between test item groups and negative control (vehicle) group. Furthermore, a statistical analysis was conducted on the ear thickness values to assess whether a statistically significant increase in ear thickness could be observed when comparing the values measured on day 1 prior to application with the values measured on days 3 or 6 in the respective test item groups or within the vehicle control group.
For all statistical calculations validated statistical program R Script DecisionTree_2.Rnw was used. Statistical significance was set at the five per cent level (p < 0.05).
However, both biological and statistical significance were considered together. - Positive control results:
- Results of the last 10 psoitive control experiments see table 3 in "any other information on results incl. tables".
- Key result
- Parameter:
- SI
- Value:
- ca. 2.55
- Test group / Remarks:
- 0.05 %
- Remarks on result:
- other: In this study Stimulation Indices (S.I.) of 2.55, 7.88 and 14.03 were determined eith the test item at concentrations of 0.05, 0.1 and 0.25 % in DMF, respectively.
- Key result
- Parameter:
- SI
- Value:
- ca. 7.88
- Test group / Remarks:
- 0.1 %
- Key result
- Parameter:
- SI
- Value:
- ca. 14.03
- Test group / Remarks:
- 0.25 %
- Interpretation of results:
- Category 1 (skin sensitising) based on GHS criteria
- Conclusions:
- The test item 2',4'-Bis(methoxycarbonyloxy)-2-brom-acetophenone was found to be a skin sensitiser under the conditions of this study.
- Executive summary:
In a study according to OECD 429 ("Skin Sensitisation: Local Lymph Node Assay") 2’,4’-Bis(methoxycarbonyloxy)-2-brom-acetophenone formulated in DMF was assessed for its possible skin sensitising potential. The test was performed in mice using test item concentrations of 0.05, 0.1 and 0.25 % (w/v). The animals did not show any signs of systemic toxicity during the course of the study and no cases of mortality were observed. From day 3 to 5, the animals treated with a test item concentration of 0.25 % showed a very slight erythema of the ear skin (Score 1). Animals treated with 0.05 and 0.1 % test item concentration did not show any signs of local skin irritation. A statistically significant increase in ear thickness was observed for day 6 in all tested dose groups as well as in ear weiht in the high dose group, when compared to the vehicle control group. However increases in ear weights and/or ear thickness were below the threshold of >= 25 % increase as described in OECD 429.
In this study Stimulation Indices (S.I.) of 2.55, 7.88 and 14.03 were determined with the test item at concentrations of 0.05, 0.1 and 0.25 % in DMF, respectively. A clear dose response was observed. Furthermore, a statistically significant increase in lymph node weight was observed in the mid and high dose group, corroborating the presence of a positive response. The EC3 value calculated was 0.054 %. Therefore the test item 2',4'-Bis(methoxycarbonyloxy)-2-brom-acetophenone was found to be a skin sensitiser under the conditions of this study.
Reference
1) Calculation and Resulte of Individual Data
Table 1: Calculation and results of individual data.
Test item concentration |
DPM values measured |
DPM-BG per animal |
S.I.b) |
||
% |
Group no. |
Animal no. |
|||
--- |
--- |
BG I |
13 |
--- |
--- |
--- |
--- |
BG II |
13 |
--- |
--- |
0 |
1 |
1 |
1384 |
1371.0 |
--- |
0 |
1 |
2 |
1097 |
1084.0 |
--- |
0 |
1 |
3 |
965 |
952.0 |
--- |
0 |
1 |
4 |
1014 |
1001.0 |
--- |
0 |
1 |
5 |
1922 |
1909.0 |
--- |
0.05 |
2 |
6 |
944 |
931.0 |
0.7 |
0.05 |
2 |
7 |
4062 |
4049.0 |
3.2 |
0.05 |
2 |
8 |
4710 |
4697.0 |
3.7 |
0.05 |
2 |
9 |
4210 |
4197.0 |
3.3 |
0.05 |
2 |
10 |
2242 |
2229.0 |
1.8 |
0.1 |
3 |
11 |
5378 |
5365.0 |
4.2 |
0.1 |
3 |
12 |
10919 |
10906.0 |
8.6 |
0.1 |
3 |
13 |
15515 |
15502.0 |
12.3 |
0.1 |
3 |
14 |
6085 |
6072.0 |
4.8 |
0.1 |
3 |
15 |
11967 |
11954.0 |
9.5 |
0.25 |
4 |
16 |
18974 |
18961.0 |
15.0 |
0.25 |
4 |
17 |
19769 |
19756.0 |
15.6 |
0.25 |
4 |
18 |
20882 |
20869.0 |
16.5 |
0.25 |
4 |
19 |
18245 |
18232.0 |
14.4 |
0.25 |
4 |
20 |
10797 |
10784.0 |
8.5 |
1 = Control Group
2-4= Test Group
a) = values corrected for mean background value (BGI and BGII)
b) = Stimulation Indices relative to the mean of the control group (Group 1)
2) Calculation of Stimulation Indices per Dose Group
Table 2: Calculation of Stimulation Indices per Dose Group
Test item concentration |
Group Calculation |
||
Mean DPM per |
SD |
S.I. |
|
Vehicle Control Group (DMF) |
1263.4 |
395.7 |
1.00 |
0.05% 2’,4’-Bis(methoxycarbonyloxy)-2-brom-acetophenone |
3220.6 |
1584.7 |
2.55 |
0.1% 2’,4’-Bis(methoxycarbonyloxy)-2-brom-acetophenone |
9959.8 |
4237.2 |
7.88 |
0.25% 2’,4’-Bis(methoxycarbonyloxy)-2-brom-acetophenone |
17720.4 |
3999.1 |
14.03 |
a) Mean DPM/animal was determined by dividing the sum of the measured values from lymph nodes of all animals within a group by the number of animals in that group (5 animals)
Calculation of the EC3 value:
|
Test item concentration % |
S.I. |
Test Group 2 |
0.05 (a) |
2.55 (b) |
Test Group 3 |
0.1 (c) |
7.88 (d) |
EC3 = (a-c) [(3-d)/(b-d)] + c = 0.054% |
a,b,c,d = Co-ordinates of the two pairs of data lying immediately above and below the S.I. value of 3 on the LLNA dose response plot.
3) Viability / Mortality
No deaths occurred during the study period.
4) Clinical Signs
No signs of systemic toxicity were observed during the study period.From day 3 to 5, the animals treated witha test item concentration of0.25% showed a very slight erythema of the ear skin (Score 1). Animals treated with 0.05 and 0.1% test item concentration did not show any signs of local skin irritation.
5) Body weights
The body weight of the animals, recordedprior to the first application and prior to treatment with3HTdR, was within the range commonly recorded for animals of this strain and age.
6) Ear Weights
The measured ear weight of all animals treated was recorded on test day 6 (after necropsy).A statistically significant increasein ear weight was observed in the high dose group in comparison to the values of the vehicle control group.
7) Ear Thickness
The measured ear thickness of all animals treated was recorded prior to the 1stapplication, on study day 3 and prior to necropsy (day 6).A statistically significant increase in ear thickness was observed for day 6 in all tested dose groups.
8) Lymph Node Weights
The measured lymph node weights of all animals treated were recorded after sacrifice.A statistically significant increase in lymph node weight was observed in the mid and high dose group.
9) Historical Positive Control Data
Table 3: Historical control data of the last 10 positive control experiments
Positive Control Substance |
Date |
Concentration / Vehicle |
S.I. values |
alpha- hexyl-cinnamaldehyde |
April 2015 |
25% in acetone:olive oil (4+1 v/v) |
9.5 |
October 2014 |
13.8 |
||
April 2014 |
6.8 |
||
October 2013 |
5.8 |
||
April 2013 |
5.9 |
||
October 2012 |
5.7 |
||
April 2012 |
3.7 |
||
February 2012 |
4.7 |
||
January 2012 |
10.8 |
||
January 2012 |
7.1 |
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed (sensitising)
Respiratory sensitisation
Endpoint conclusion
- Endpoint conclusion:
- no study available
- Additional information:
The dermal sensitisation potential of 2',4'-Bis(methoxycarbonyloxy)-2 -brom-acetophenone was assessed in accordance with OECD guideline 429 ("Skin Sensitisation: Local Lymph Node Assay").
Under the conditions of the study 2',4'-Bis(methoxycarbonyloxy)-2 -brom-acetophenone showed sensitising potential.
Justification for classification or non-classification
The dermal sensitisation potential of 2',4'-Bis(methoxycarbonyloxy)-2 -brom-acetophenone was assessed in accordance with OECD guideline 429 ("Skin Sensitisation: Local Lymph Node Assay").
Under the conditions of the study 2',4'-Bis(methoxycarbonyloxy)-2 -brom-acetophenone showed sensitising potential and was as a skin sensitising substance.
Therefore the substance 2',4'-Bis(methoxycarbonyloxy)-2-brom-acetophenone has to be classified as Skin. Sens. 1 with "H317: May cause an allergic skin reaction".
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.